V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220014625 | 220009233 | null | 109 | Curative (C) | 2014-02-24 | 2014-03-02 | Clofarabine + Cytarabine | null | null | 220034750 | ECX |
| 220014626 | 220018137 | 0 | 62.9 | Palliative (P) | 2013-10-16 | 2013-10-17 | IDARUBICIN | N | N | 220034754 | IDARUBICIN |
| 220014627 | 220009234 | 1.69 | 63 | Curative (C) | 2016-04-06 | 2016-09-12 | GemCarbo Days 1+8 | 2 | N | 220034758 | UKALL2014 |
| 220014631 | 220021007 | 1.77 | 86.9 | Palliative (P) | 2015-01-05 | 2015-03-08 | UKALL14- Intens/CNS Proph | 02 | N | 220034780 | PONATINIB |
| 220014632 | 220009235 | 1.73 | 96.5 | Palliative (P) | 2017-12-22 | 2018-01-25 | CISPLATIN + GEMCITABINE | N | N | 220034781 | ECX |
| 220014633 | 220009236 | null | 71.4 | Curative (C) | 2014-11-06 | 2015-01-03 | IDARUBICIN | null | null | 220034784 | IDARUBICIN |
| 220014634 | 220009237 | 1.83 | 61.1 | Palliative (P) | 2014-11-03 | 2014-11-05 | ECX | 02 | N | 220034796 | GEMCARBO |
| 220014635 | 220009241 | null | 82.1 | null | 2017-08-14 | 2018-01-06 | IDARUBICIN | N | N | 220034798 | IDARUBICIN |
| 220014636 | 220009241 | 1.5 | 78.2 | Curative (C) | 2013-05-10 | 2013-05-10 | Fludarabine + Melphalan RIC Allo | 02 | N | 220034798 | FLUDARABINE + MELPHALAN |
| 220014637 | 220009243 | 1.77 | 73 | Palliative (P) | 2015-09-03 | 2015-09-03 | Clofarabine + Cytarabine | N | N | 220034800 | CISPLATIN + GEMCITABINE |
| 220014638 | 220009244 | 1.68 | 53.85 | Palliative (P) | 2015-09-16 | 2015-09-16 | Mitoxantrone | N | N | 220034800 | MITOXANTRONE |
| 220014639 | 220009244 | 1.55 | 66.7 | Curative (C) | null | 2014-11-05 | GEMTUZUMAB OZOGAMICIN | N | N | 220034800 | GEMCARBO |
| 220014640 | 220009245 | 1.71 | 91.9 | Curative (C) | 2016-04-11 | 2016-07-04 | Cytarabine intrathecal | N | N | 220034807 | CYTARABINE INTRATHECAL |
| 220014641 | 220009246 | 1.71 | 69 | Curative (C) | 2014-07-29 | 2014-07-29 | PONATINIB | 2 | N | 220034818 | OXALIPLATIN + MDG |
| 220014642 | 220014917 | 1.65 | 73.35 | Curative (C) | 2013-07-21 | 2013-07-21 | Alemtuzumab cond (RI ALLO CAMP100) | 2 | N | 220034818 | ALEMTUZUMAB |
| 220014643 | 220021008 | 1.87 | null | Curative (C) | 2016-03-21 | 2016-08-09 | Cytarabine intrathecal | N | N | 220034820 | CYTARABINE INTRATHECAL |
| 220014646 | 220009248 | 1.79 | 72.2 | Adjuvant (A) | 2015-04-03 | 2015-06-20 | ECX | N | N | 220034830 | CISPLATIN + GEMCITABINE |
| 220014647 | 220009251 | 1.53 | 55 | Curative (C) | 2015-04-30 | 2015-04-30 | Cytarabine intrathecal | N | N | 220034845 | CYTARABINE INTRATHECAL |
| 220014648 | 220009252 | null | 87.2 | Curative (C) | 2014-06-21 | 2014-07-05 | IDARUBICIN | 02 | null | 220034848 | IDARUBICIN |
| 220014649 | 220009253 | 1.74 | 55.5 | Adjuvant (A) | 2016-10-22 | 2016-12-10 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 220034849 | PACLITAXEL |
| 220014650 | 220014921 | 1.55 | 73.9 | Curative (C) | 2013-02-26 | 2013-02-26 | PONATINIB | N | N | 220034854 | OXALIPLATIN + MDG |
| 220014651 | 220014921 | 1.65 | null | Curative (C) | 2013-09-01 | 2013-09-02 | PACLITAXEL | N | N | 220034854 | PACLITAXEL |
| 220014652 | 220014921 | 0 | 47 | Curative (C) | 2015-05-06 | 2015-05-06 | IDARUBICIN | 02 | N | 220034854 | IDARUBICIN |
| 220014653 | 220009254 | 1.76 | 75.7 | Adjuvant (A) | 2016-11-30 | 2017-07-24 | IDARUBICIN | null | null | 220034881 | IDARUBICIN |
| 220014654 | 220009254 | 1.55 | null | Curative (C) | 2016-12-10 | 2016-12-11 | PONATINIB | N | null | 220034881 | CLOFARABINE + CYTARABINE |
| 220014655 | 220009255 | null | 84 | Curative (C) | 2017-08-25 | 2017-08-25 | Clofarabine + Cytarabine | null | null | 220034891 | CLOFARABINE + CYTARABINE |
| 220014656 | 220009256 | null | 70 | Palliative (P) | 2015-08-03 | 2015-08-12 | Mitoxantrone | null | null | 220034893 | MITOXANTRONE |
| 220014658 | 220009258 | 0 | 60 | Disease modification (D) | null | 2018-09-15 | Mitoxantrone | N | N | 220034905 | MITOXANTRONE |
| 220014659 | 220009258 | 1.85 | 78.45 | Palliative (P) | 2013-09-20 | 2013-09-23 | Alemtuzumab cond (RI ALLO CAMP100) | N | N | 220034905 | ALEMTUZUMAB |
| 220014660 | 220018146 | null | 88.3 | Curative (C) | 2013-07-05 | 2013-07-05 | Cytarabine intrathecal | N | N | 220034910 | CYTARABINE INTRATHECAL |
| 220014661 | 220018146 | 1.63 | null | Curative (C) | 2016-08-07 | 2016-08-12 | Arsenic trioxide + Tretinoin | Y | N | 220034910 | ARSENIC TRIOXIDE + TRETINOIN |
| 220014662 | 220009259 | 1.86 | 64 | Curative (C) | 2014-02-16 | 2014-02-16 | CARBOPLATIN + ETOPOSIDE | N | N | 220034927 | CARBOPLATIN + ETOPOSIDE |
| 220014663 | 220009261 | 1.66 | 66.7 | Curative (C) | 2016-05-09 | 2016-05-20 | ALEMTUZUMAB + BUSULFAN + FLUDARABINE | 02 | N | 220034933 | UKALL2014 |
| 220014664 | 220009264 | 1.68 | 80.2 | Palliative (P) | 2014-04-21 | 2014-04-21 | Carboplatin + Etoposide IV 3 day | N | N | 220034935 | CARBOPLATIN + ETOPOSIDE |
| 220014665 | 220009267 | 1.64 | null | Curative (C) | 2017-04-01 | 2017-04-02 | UKALL 14 TRIAL | 02 | null | 220034936 | CISPLATIN + GEMCITABINE |
| 220014666 | 220014927 | 1.08 | 106 | Palliative (P) | 2016-10-03 | 2016-10-03 | Cisplatin + Gemcitabine (D 1 & 8) | 2 | N | 220034939 | CLOFARABINE + CYTARABINE |
| 220014667 | 220009268 | 1.56 | 81 | Curative (C) | 2017-03-30 | 2017-04-01 | Clofarabine + Cytarabine | N | null | 220034947 | UKALL2014 |
| 220014668 | 220009269 | 1.78 | 77.1 | Disease modification (D) | 2016-05-23 | 2016-05-27 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 220034961 | UKALL2014 |
| 220014669 | 220009270 | null | 62.3 | null | 2016-08-06 | 2018-09-21 | Fludarabine + Melphalan RIC Allo | 02 | N | 220034968 | DOCETAXEL |
| 220014670 | 220009271 | 1.8 | 82 | Palliative (P) | 2013-08-14 | 2013-08-25 | Arsenic trioxide + Tretinoin | 2 | N | 220034971 | ARSENIC TRIOXIDE + TRETINOIN |
| 220014671 | 220009271 | null | 96.4 | Curative (C) | 2016-09-08 | 2017-04-10 | Paclitaxel 80mg/m2 day 1 8 15 | null | null | 220034971 | PACLITAXEL |
| 220014673 | 220009272 | 1.55 | 90 | Disease modification (D) | null | 2016-07-20 | CISPLATIN + GEMCITABINE | 2 | N | 220035003 | GEMTUZUMAB OZOGAMICIN |
| 220014674 | 220009272 | 1.57 | 58.8 | Curative (C) | 2017-11-20 | 2017-11-20 | CARBOPLATIN + GEMCITABINE | 2 | N | 220035003 | OXALIPLATIN + MDG |
| 220014677 | 220021010 | 1.78 | 96.4 | Palliative (P) | null | 2013-11-12 | Alemtuzumab cond (RI ALLO CAMP100) | N | N | 220035027 | ALEMTUZUMAB |
| 220014679 | 220009274 | null | 89 | Palliative (P) | 2014-07-19 | 2014-07-20 | Alemtuzumab | N | N | 220035056 | ALEMTUZUMAB |
| 220014680 | 220009274 | 1.53 | 56.8 | Curative (C) | 2017-05-20 | 2017-05-20 | Carboplatin + Etoposide IV 3 day | 02 | null | 220035056 | CARBOPLATIN + ETOPOSIDE |
| 220014681 | 220009275 | 1.66 | 73.9 | Curative (C) | 2014-03-08 | 2014-03-08 | Mitoxantrone | 02 | N | 220035062 | MITOXANTRONE |
| 220014682 | 220009276 | 1.65 | 66 | Palliative (P) | 2016-03-20 | 2016-03-24 | FLUOROURACIL + IRINOTECAN | N | N | 220035065 | UKALL2014 |
| 220014684 | 220009282 | 1.66 | null | Curative (C) | 2017-02-15 | 2017-02-15 | Irinotecan + De Gramont | null | null | 220035075 | METHOTREXATE |
| 220014685 | 220009283 | 1.71 | 108 | Palliative (P) | 2017-10-26 | 2017-10-27 | PONATINIB | N | N | 220035089 | UKALL2014 |